Cerevel Therapeutics Holdings, Inc.
CEREDelisted Aug 1, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Cerevel Therapeutics Holdings, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 109
- +5 vs. Q1 2022
- Shares held
- 124.1M
- +2.09M (+1.7%) vs. Q1 2022
- Total value
- $3.28B
- −$989.1M (−23.2%) vs. Q1 2022
- New holders
- 19
- 51 more added
- Sold out
- 14
- 24 more reduced
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CERE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $1.16K |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 2 | $20.7K |
| Q2 2024 | 231 | $6.42B |
| Q1 2024 | 210 | $6.67B |
| Q4 2023 | 195 | $6.61B |
| Q3 2023 | 119 | $3.07B |
| Q2 2023 | 125 | $4.41B |
| Q1 2023 | 119 | $3.30B |
| Q4 2022 | 125 | $4.23B |
| Q3 2022 | 115 | $3.76B |
| Q2 2022 | 109 | $3.28B |
| Q1 2022 | 107 | $4.27B |
| Q4 2021 | 107 | $3.84B |
| Q3 2021 | 94 | $3.51B |
| Q2 2021 | 82 | $2.65B |
| Q1 2021 | 62 | $1.37B |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Cerevel Therapeutics Holdings, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rock Springs Capital Management LP | 1,767,141 | $46.7M | 1.36% | +43,800+2.5% | Added |
| State Street Corp | 2,414,474 | $63.8M | 0.00% | +252,378+11.7% | Added |
| Federated Hermes, Inc. | 3,113,333 | $82.3M | 0.22% | 00.0% | Unchanged |
| BlackRock Inc. | 4,132,287 | $109.3M | 0.00% | +740,872+21.8% | Added |
| Vanguard Group Inc | 5,012,420 | $132.5M | 0.00% | +202,727+4.2% | Added |
| Perceptive Advisors LLC | 5,086,727 | $134.5M | 4.23% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 6,295,908 | $166.5M | 0.02% | −182,102−2.8% | Reduced |
| FMR LLC | 22,243,384 | $588.1M | 0.06% | +39,383+0.2% | Added |
| Bain Capital Investors LLC | 60,632,356 | $1.60B | 33.55% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −105,000−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −82,135−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −45,371−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −23,434−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −10,268−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −9,900−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −9,403−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −8,835−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −7,642−100.0% | Sold out |
| Centaurus Financial, Inc. | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −149−100.0% | Sold out |
| Fortitude Advisory Group L.L.C. | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| TCWP LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Virginia Retirement Systems Et Al | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |